camptothecin has been researched along with rosettacin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cinelli, MA; Cushman, M; Dexheimer, TS; Morrell, A; Pommier, Y; Scher, ES | 1 |
| Cinelli, MA; Cordero, B; Cushman, M; Dexheimer, TS; Pommier, Y | 1 |
| Agama, K; Agrawal, S; Cinelli, MA; Cushman, M; Dexheimer, TS; Morrell, AE; Pommier, Y | 1 |
3 other study(ies) available for camptothecin and rosettacin
| Article | Year |
|---|---|
Design, synthesis, and biological evaluation of 14-substituted aromathecins as topoisomerase I inhibitors.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; DNA; DNA Topoisomerases, Type I; Drug Design; Humans; Indolizines; Ligands; Models, Molecular; Molecular Structure; Protein Binding; Quinolines; Structure-Activity Relationship; Topoisomerase I Inhibitors | 2008 |
Synthesis and biological evaluation of 14-(aminoalkyl-aminomethyl)aromathecins as topoisomerase I inhibitors: investigating the hypothesis of shared structure-activity relationships.
Topics: Antineoplastic Agents; Drug Evaluation, Preclinical; Enzyme Inhibitors; Magnetic Resonance Spectroscopy; Models, Molecular; Structure-Activity Relationship; Topoisomerase I Inhibitors | 2009 |
The structure-activity relationships of A-ring-substituted aromathecin topoisomerase I inhibitors strongly support a camptothecin-like binding mode.
Topics: Antineoplastic Agents; Camptothecin; DNA Topoisomerases, Type I; Enzyme Inhibitors; Humans; Isoquinolines; Models, Molecular; Protein Binding; Structure-Activity Relationship; Topoisomerase I Inhibitors | 2010 |